Nephros (NEPH) EBT Growth (3y) (2013 - 2026)
Powered by 
Analysis
Nephros (NEPH) EBT Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.01 Bn | 172.41 Bn | 7.27 Bn | -2.34% |
| 2 | Intuitive Surgical | 131.29 Bn | 126.08 Bn | 1.96 Bn | 28.31% |
| 3 | Medtronic | 116.38 Bn | 107.56 Bn | 6.34 Bn | 13.94% |
| 4 | Stryker | 106.01 Bn | 102.53 Bn | 4.50 Bn | 20.27% |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | 35.51% |
| 6 | Edwards Lifesciences | 48.89 Bn | 44.64 Bn | 1.35 Bn | 23.63% |
| 7 | Alcon | 32.59 Bn | 31.13 Bn | 1.68 Bn | -30.37% |
| 8 | Dexcom | 31.84 Bn | 29.89 Bn | 830.00 Mn | 25.85% |
| 9 | Steris | 20.61 Bn | 20.13 Bn | 684.20 Mn | 17.92% |
| 10 | Nephros | 48.31 Mn | 43.62 Mn | 4.03 Mn | 69.47% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 69.47% |
| Mar 31, 2026 | 32.74% |
| Dec 31, 2025 | 27.85% |
| Sep 30, 2025 | 31.34% |
| Jun 30, 2025 | 32.01% |
| Mar 31, 2025 | 32.90% |
| Dec 31, 2024 | 35.75% |
| Sep 30, 2024 | 30.57% |
| Jun 30, 2024 | 36.43% |
| Mar 31, 2024 | 41.29% |
| Dec 31, 2023 | -4.49% |
| Sep 30, 2023 | 41.34% |
| Jun 30, 2023 | 36.19% |
| Mar 31, 2023 | 34.87% |
| Dec 31, 2022 | -25.81% |
| Sep 30, 2022 | -19.91% |
| Jun 30, 2022 | 3.59% |
| Mar 31, 2022 | -4.88% |
| Dec 31, 2021 | 1.25% |
| Sep 30, 2021 | -14.33% |